{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:24:38Z","timestamp":1753521878743},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.gofs.2018.10.011","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T14:46:45Z","timestamp":1540824405000},"page":"786-791","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interactions avec les contraceptifs. RPC Contraception CNGOF"],"prefix":"10.1016","volume":"46","author":[{"given":"M.","family":"Bernier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-P.","family":"Jonville-Bera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2018.10.011_bib0165","first-page":"10","article-title":"Drug-interaction leading to unintended pregnancy: analysis of the French PharmacoVigilance Database (abstract)","volume":"30","author":"Agier","year":"2016","journal-title":"Fundam Clin Pharmacol"},{"issue":"7262","key":"10.1016\/j.gofs.2018.10.011_bib0170","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bmj.321.7262.674","article-title":"Population based, prospective study of the care of women with epilepsy in pregnancy","volume":"321","author":"Fairgrieve","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2018.10.011_bib0175","doi-asserted-by":"crossref","unstructured":"Mattson RH, Cramer JA, Darney PD, Naftolin F. Use of oral contraceptives by women with epilepsy. JAMA 1986;256(2):238\u201340.","DOI":"10.1001\/jama.1986.03380020100031"},{"issue":"9","key":"10.1016\/j.gofs.2018.10.011_bib0180","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jgyn.2016.03.013","article-title":"Safety profile of etonogestrel contraceptive implant (Nexplanon\u00ae and Implanon\u00ae) reported in France","volume":"45","author":"Simon","year":"2016","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.gofs.2018.10.011_bib0185","unstructured":"ANSM. R\u00e9f\u00e9rentiel national des interactions m\u00e9dicamenteuses (mise \u00e0 jour du 18\/5\/2018\u00a0; http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/a90a7e83a649086c46aa73ea1f9e1b56.pdf\u00a0; consult\u00e9 le 24\/05\/2018."},{"key":"10.1016\/j.gofs.2018.10.011_bib0190","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2012.01.010","article-title":"Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal women","volume":"86","author":"Blode","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.10.011_bib0195","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","article-title":"Clinically relevant drug interactions with antiepileptic drugs","volume":"61","author":"Perrucca","year":"2005","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.011_bib0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2349-0977.192712","article-title":"Contraception in women with epilepsy: potential drug interactions between contraceptive hormones and enzyme inducing antiepileptic drugs","volume":"3","author":"Bansal","year":"2016","journal-title":"Astrocyte"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.011_bib0205","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.contraception.2004.10.005","article-title":"Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia","volume":"71","author":"Harrison-Woolrych","year":"2005","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.011_bib0210","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.contraception.2011.09.005","article-title":"Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz","volume":"85","author":"Leticee","year":"2012","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.011_bib0215","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.clpt.6100040","article-title":"Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions","volume":"81","author":"Cohn","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.011_bib0220","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/QAD.0000000000001392","article-title":"Drug interactions between hormonal contraceptives and antiretrovirals","volume":"31","author":"Nanda","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.gofs.2018.10.011_bib0225","first-page":"113","volume":"Volume 83","author":"Dutton","year":"2008"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.011_bib0230","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/1471-0528.15027","article-title":"Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review","volume":"125","author":"Simmons","year":"2018","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.10.011_bib0235","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.antiviral.2009.07.017","article-title":"Pharmacokinetics and drug-drug interactions of antiretrovirals: an update","volume":"85","author":"Dickinson","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.gofs.2018.10.011_bib0240","unstructured":"Site HIV-Drug interactions https:\/\/www.hiv-druginteractions.org\/. Consult\u00e9 le 24\/05\/2018."},{"key":"10.1016\/j.gofs.2018.10.011_bib0245","first-page":"853","article-title":"Council on Scientific Affairs, American Medical Association. Drug interactions between oral contraceptives and antibiotics","volume":"98","author":"Dickinson","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.011_bib0250","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/pds.3267","article-title":"Are antibiotics related to oral combination contraceptive failures in the Netherlands? A case-crossover study","volume":"21","author":"Koopmans","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.011_bib0255","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajog.2017.07.003","article-title":"Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review","volume":"218","author":"Simmons","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.10.011_bib0260","series-title":"Stockley's drug interactions","year":"2002"},{"key":"10.1016\/j.gofs.2018.10.011_bib0265","unstructured":"HAS contraception_hormonale__maj_janv2015.pdf [Internet]. [cit\u00e9 23\u00a0nov 2017]. Disponible sur\u00a0: https:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2015-02\/contraception_hormonale__maj_janv2015.pdf."},{"issue":"4","key":"10.1016\/j.gofs.2018.10.011_bib0270","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1212\/01.WNL.0000076485.09353.7A","article-title":"Oral contraceptives reduce lamotrigine plasma levels","volume":"61","author":"Sabers","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.011_bib0275","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ane.12197","article-title":"Effect of oral contraceptives on lamotrigine levels depends on comedication","volume":"129","author":"Wegner","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.gofs.2018.10.011_bib0280","first-page":"2785","article-title":"A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception","volume":"30","author":"Brache","year":"2015","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.011_bib0285","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.contraception.2016.07.010","article-title":"Co-administration of St. John's wort and hormonal contraceptives: a systematic review","volume":"94","author":"Berry-Bibee","year":"2016","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.011_bib0290","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1503\/cmaj.120951","article-title":"Grapefruit\u2013medication interactions: forbidden fruit or avoidable consequences?","volume":"185","author":"Bailey","year":"2013","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.011_bib0295","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0010-7824(95)00252-9","article-title":"Can grapefruit juice influence ethinylestradiol bioavailability?","volume":"53","author":"Weber","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.10.011_bib0300","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(09)60289-0","article-title":"Attention grapefruit!","volume":"373","author":"Grande","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.011_bib0305","first-page":"78","article-title":"Observational series on women using the contraceptive Mirena\u00ae concurrently with anti-epileptic and other enzyme-inducing drugs","volume":"28","author":"Bounds","year":"2002","journal-title":"BMJ Sex Reprod Health"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.011_bib0310","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0028-2243(89)90037-3","article-title":"Intra-uterine device failure: relation with drug use","volume":"32","author":"Papiernik","year":"1989","journal-title":"Eur J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.10.011_bib0315","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1093\/humrep\/del208","article-title":"Risk factors for IUD failure: results of a large multicentre case-control study","volume":"21","author":"Thonneau","year":"2006","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.011_bib0160","first-page":"CD006034","article-title":"Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use","volume":"18","author":"Grimes","year":"2006","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T09:15:07Z","timestamp":1572340507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718918302666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2468718918302666"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.011","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions avec les contraceptifs. RPC Contraception CNGOF","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}